Carman Alenson is Principal Accounting Officer of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of AGIO, which is worth approximately $0. The most recent transaction as insider was on Jun 21, 2021, when has been sold 1,777 shares (Common Stock) at a price of $61.61 per share, resulting in proceeds of $109,481. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Carman Alenson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 21 2021
SELL
Open market or private sale
$109,481 $61.61 p/Share
1,777 Reduced 100.0%
0 Common Stock
Jun 21 2021
BUY
Exercise of conversion of derivative security
$91,533 $51.51 p/Share
1,777 Added 50.0%
1,777 Common Stock
Apr 16 2021
SELL
Open market or private sale
$62,485 $55.89 p/Share
1,118 Reduced 100.0%
0 Common Stock
Apr 15 2021
SELL
Open market or private sale
$53,514 $54.0 p/Share
991 Reduced 46.99%
1,118 Common Stock
Feb 22 2021
SELL
Payment of exercise price or tax liability
-
199 Reduced 9.98%
1,795 Common Stock
Feb 22 2021
BUY
Exercise of conversion of derivative security
-
692 Added 25.76%
1,994 Common Stock
Feb 16 2021
SELL
Payment of exercise price or tax liability
-
561 Reduced 30.11%
1,302 Common Stock
Feb 16 2021
BUY
Exercise of conversion of derivative security
-
790 Added 29.78%
1,863 Common Stock
Feb 14 2021
BUY
Exercise of conversion of derivative security
-
889 Added 45.31%
1,073 Common Stock

Also insider at

PRME
Prime Medicine, Inc.
CA

Carman Alenson

Principal Accounting Officer
Cambridge, MA

Track Institutional and Insider Activities on AGIO

Follow AGIOS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGIO shares.

Notify only if

Insider Trading

Get notified when an Agios Pharmaceuticals, Inc. insider buys or sells AGIO shares.

Notify only if

News

Receive news related to AGIOS PHARMACEUTICALS, INC.

Track Activities on AGIO